Springwell Veterinary Surgery has been transferred to an Employee Ownership Trust
October 2024 — Springwell Veterinary Surgery has become employee owned after transferring into an Employee Ownership Trust (EOT).
Located in a purpose-built, modern facility in Tring, Hertfordshire, UK, Springwell Veterinary Surgery is a well-established and highly regarded small animal practice. The practice employs a team of approximately 25 staff members.
The shareholders have decided to transfer the company to an EOT, allowing employees to benefit from the future growth of the business. EOTs, created by the UK government in 2014, give business owners the opportunity to sell their shares to an employee-owned trust without incurring capital gains tax.
Our role in the transaction
Oaklins S&W, one of Oaklins’ member firms in the UK, worked with the shareholders of Edendene Limited, trading as Springwell Veterinary Surgery, to deliver a successful transfer to an Employee Ownership Trust.
Talk to the deal team
Related deals
Mattina Holding has sold a 5% stake in Gens Aurea via accelerated bookbuild
Mattina Holding S.A. (DVC Partners) has sold a 5% stake in Italian company Gens Aurea S.p.A. through an accelerated bookbuild, raising approximately US$69.96 million.
Learn moreTNT has been acquired by PM Studio
TNT Group has been acquired by PM Studio Group, backed by Andera Partners, bringing together two complementary specialists in premium packaging for the beauty and luxury industries. TNT’s expertise in bespoke primary packaging complements PM Studio’s secondary packaging, gifting and creative design capabilities, creating a broader, integrated offering for major luxury brands. The transaction strengthens the group’s geographical footprint in Asia and the USA, diversifying its customer portfolio. The combined group generates over US$145 million in revenue and has approximately 150 employees worldwide. Following the transition of operational leadership to CEO Damon Kennish, the founders completed the sale to PM Studio while making a significant reinvestment alongside the management team, demonstrating their confidence in the combined group’s long-term potential. It aims to reach US$280 million in revenue by 2029 through organic growth, commercial synergies and further acquisitions.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn more